Company Filing History:
Years Active: 2025
Title: Ozlem Unal: Innovator in Therapeutic Nanoparticles
Introduction
Ozlem Unal is a prominent inventor based in Istanbul, Turkey. She has made significant contributions to the field of gene therapy through her innovative work on therapeutic nanoparticles. Her research focuses on the delivery of microRNA, which has the potential to revolutionize treatment methods for various diseases, particularly cancer.
Latest Patents
Ozlem Unal holds a patent for "Therapeutic nanoparticles containing argonaute for microRNA delivery and compositions and methods using same." This invention relates to oligonucleotide carriers designed for effective gene therapy. The therapeutic nanoparticles developed by Unal utilize the natural gene carrier Argonaute (AGO) protein to bind microRNA to biocompatible nanoparticles. These nanoparticles can also include targeting moieties to direct them specifically to cancer cells, enhancing the efficacy of treatment. Additionally, the nanoparticles can be designed to be trackable, such as using superparamagnetic iron oxide nanoparticles (SPION), which allows for multifunctional theranostics.
Career Highlights
Throughout her career, Ozlem Unal has worked at prestigious institutions, including Koc University and Sabanci University. Her research has garnered attention for its innovative approach to gene therapy and its potential applications in medical treatments.
Collaborations
Ozlem has collaborated with notable colleagues, including Havva Yagci Acar and Devrim Gozuacik. These collaborations have contributed to the advancement of her research and the development of her patented technologies.
Conclusion
Ozlem Unal is a trailblazer in the field of therapeutic nanoparticles, with her innovative patent paving the way for new gene therapy methods. Her work exemplifies the intersection of technology and medicine, showcasing the potential for significant advancements in cancer treatment.